Overview

Intravenous Oliceridine and Opioid-related Complications

Status:
Recruiting
Trial end date:
2025-07-15
Target enrollment:
Participant gender:
Summary
The investigator will evaluate the side effects of oliceridine.
Phase:
Phase 3
Details
Lead Sponsor:
The Cleveland Clinic